Company Profile

ZYDUS WELLNESS LTD.

NSE : ZYDUSWELLBSE : 531335ISIN CODE : INE768C01010Industry : Consumer FoodHouse : Cadila
BSE1378.0517.95 (+1.32 % )
PREV CLOSE (Rs.) 1360.10
OPEN PRICE (Rs.) 1364.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 292
TODAY'S LOW / HIGH (Rs.)1357.60 1381.95
52 WK LOW / HIGH (Rs.)1085 1830
NSE1375.90 17.7 (+1.3 % )
PREV CLOSE(Rs.) 1358.20
OPEN PRICE (Rs.) 1363.05
BID PRICE (QTY) 1375.90 (29 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 29121
TODAY'S LOW / HIGH(Rs.) 1352.35 1384.00
52 WK LOW / HIGH (Rs.)1087.95 1980

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 4.00655
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 37.82
ROCE (%) 4.53
Incorporation Year : 1994

Management Info :

Sharvil P Patel - Chairman - Managing Director

Registered Office :

Address : House No. 6 & 7,Sigma Commerce Zone,Nr. Iscon Temple, Sarkhej - Gandhinagar Highway,
Ahmedabad,
Gujarat-380015

Phone : 079-67775888

Registrar's Details : Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, MCX
NEWS More
24May05-24-2019$NCLT approves amalgamation of Zydus Wellness' two subsidiaries NCLT approves amalgamation o

National Company Law Tribunal (NCLT), Bench at Ahmedabad has given an approval to Zydus Wellness for the Scheme of Amalgamation (Scheme) between two subsidiaries, Heinz India (Heinz) with Zydus Nutritions (ZNL). Upon amalgamation, Heinz has ceased to be in existence and also to be the subsidiary of the company. The effective date of the Scheme is May 24, 2019.

Zydus Wellness is an integrated consumer company. The company is engaged in the development, production, marketing and distribution of health and wellness products.

National Company Law Tribunal (NCLT), Bench at Ahmedabad has gi..
24May05-24-2019$Zydus Wellness informs about amalgamation of subsidiary companies Zydus Wellness informs about

Zydus Wellness has informed that Hon’ble National Company Law Tribunal, Bench at Ahmedabad has passed an order dated May 10, 2019 approving the Scheme of Amalgamation (Scheme) between two subsidiaries, Heinz India Private Limited (Heinz) with Zydus Nutritions Limited (ZNL). Upon amalgamation, Heinz has ceased to be in existence and also to be the subsidiary of the Company. The effective date of the Scheme is May 24, 2019.

The above information is a part of company’s filings submitted to BSE.

Zydus Wellness has informed that Hon’ble National Company Law..
24May05-24-2019$Zydus Wellness trades in green on the bourses Zydus Wellness trades in gre

Zydus Wellness is currently trading at Rs. 1286.00, up by 12.75 points or 1.00% from its previous closing of Rs. 1273.25 on the BSE.

The scrip opened at Rs. 1291.70 and has touched a high and low of Rs. 1291.70 and Rs. 1263.75 respectively. So far 35 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1830.00 on 03-Sep-2018 and a 52 week low of Rs. 1085.00 on 15-Nov-2018.

Last one week high and low of the scrip stood at Rs. 1302.75 and Rs. 1255.85 respectively. The current market cap of the company is Rs. 7298.84 crore.

The promoters holding in the company stood at 67.62%, while Institutions and Non-Institutions held 10.71% and 21.67% respectively.

National Company Law Tribunal (NCLT), Bench at Ahmedabad has given an approval to Zydus Wellness for the Scheme of Amalgamation (Scheme) between two subsidiaries, Heinz India (Heinz) with Zydus Nutritions (ZNL). Upon amalgamation, Heinz has ceased to be in existence and also to be the subsidiary of the company. The effective date of the Scheme is May 24, 2019.

Zydus Wellness is an integrated consumer company. The company is engaged in the development, production, marketing and distribution of health and wellness products.

Zydus Wellness is currently trading at Rs. 1286.00, up by 12.75..
14May05-14-2019$ Clarification Clarification
The Exchange had sought clarification from Zydus Wellness Ltd with reference to the media report, https://economictimes.indiatimes.com/ May 13, 2019, "Pharma stocks bleed as US states file lawsuit against generic drug firms " The company response is enclosed. Declaration of NAV
The Exchange had sought clarification from Zydus Wellness Ltd w..
13May05-13-2019$ Clarification sought from Zydus Wellness Ltd Clarification sought from Z
The Exchange has sought clarification from Zydus Wellness Ltd with respect to news article appearing on https://economictimes.indiatimes.com May 13, 2019 titled "Pharma stocks bleed as US states file lawsuit against generic drug firms ". The reply is awaited. Declaration of NAV
The Exchange has sought clarification from Zydus Wellness Ltd w..
Financials More
Rs. in Millions
QTR Mar 19 ANNUAL 19
Net Profit-100.9963
Gross Profit -98.1 971.6
Operating Profit 194.91297
Net Sales 341.12546.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Glaxo.Cons. Health (BSE)
 7532.65 (0.96%)
M.Cap ( in Cr)
31678.96
Britannia Inds (BSE)
 2797.25 (1.78%)
M.Cap ( in Cr)
67223.03
Amrit Corp (BSE)
 578.55 (5.00%)
M.Cap ( in Cr)
185.90
Coastal Corporation (BSE)
 280.25 (4.65%)
M.Cap ( in Cr)
284.98
Vadilal Industries (BSE)
 549.40 (1.82%)
M.Cap ( in Cr)
394.90
Shareholding Pattern More
NON-INSTITUTION 8.96 %
PROMOTERS 67.62 %
MUTUAL FUNDS/UTI 2.73 %
FI/BANKS/INSURANCE 2.64 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes